Cargando…

Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer

Utilizing molecular data to derive functional physiological models tailored for specific cancer cells can facilitate the use of individually tailored therapies. To this end we present an approach termed PRIME for generating cell-specific genome-scale metabolic models (GSMMs) based on molecular and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yizhak, Keren, Gaude, Edoardo, Le Dévédec, Sylvia, Waldman, Yedael Y, Stein, Gideon Y, van de Water, Bob, Frezza, Christian, Ruppin, Eytan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2014
Materias:	Cell Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238051/ https://www.ncbi.nlm.nih.gov/pubmed/25415239 http://dx.doi.org/10.7554/eLife.03641

Ejemplares similares

A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration
por: Yizhak, Keren, et al.
Publicado: (2014)

A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration
por: Yizhak, Keren, et al.
Publicado: (2014)

Integrating Transcriptomics with Metabolic Modeling Predicts Biomarkers and Drug Targets for Alzheimer's Disease
por: Stempler, Shiri, et al.
Publicado: (2014)

A Genome-Wide Systematic Analysis Reveals Different and Predictive Proliferation Expression Signatures of Cancerous vs. Non-Cancerous Cells
por: Waldman, Yedael Y., et al.
Publicado: (2013)

Modeling cancer metabolism on a genome scale
por: Yizhak, Keren, et al.
Publicado: (2015)

Metabolic modeling of endosymbiont genome reduction on a temporal scale
por: Yizhak, Keren, et al.
Publicado: (2011)

Metabolic modeling predicts perturbations extending lifespan in yeast and counteracting aging in mammalian muscle
por: Yizhak, Keren, et al.
Publicado: (2012)

Selection for Translation Efficiency on Synonymous Polymorphisms in Recent Human Evolution
por: Waldman, Yedael Y., et al.
Publicado: (2011)

Enhancing the Prioritization of Disease-Causing Genes through Tissue Specific Protein Interaction Networks
por: Magger, Oded, et al.
Publicado: (2012)

Density-Dependent Migration Characteristics of Cancer Cells Driven by Pseudopod Interaction
por: Burger, Gerhard A., et al.
Publicado: (2022)

Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model
por: Yizhak, Keren, et al.
Publicado: (2010)

Translation efficiency in humans: tissue specificity, global optimization and differences between developmental stages
por: Waldman, Yedael Y., et al.
Publicado: (2010)

Defects in mitochondrial metabolism and cancer
por: Gaude, Edoardo, et al.
Publicado: (2014)

Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival
por: Gaude, Edoardo, et al.
Publicado: (2016)

Essential Genes Embody Increased Mutational Robustness to Compensate for the Lack of Backup Genetic Redundancy
por: Cohen, Osher, et al.
Publicado: (2016)

Maximal Sum of Metabolic Exchange Fluxes Outperforms Biomass Yield as a Predictor of Growth Rate of Microorganisms
por: Zarecki, Raphy, et al.
Publicado: (2014)

Predicting selective drug targets in cancer through metabolic networks
por: Folger, Ori, et al.
Publicado: (2011)

Predicting selective drug targets in cancer through metabolic networks
por: Folger, Ori, et al.
Publicado: (2011)

Predicting selective drug targets in cancer through metabolic networks
por: Folger, Ori, et al.
Publicado: (2011)

p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production
por: Goldstein, Ido, et al.
Publicado: (2013)

Metabolic Reprograming of Mononuclear Phagocytes in Progressive Multiple Sclerosis
por: Tannahill, Gillian Margaret, et al.
Publicado: (2015)

A 3D engineered tumour for spatial snap-shot analysis of cell metabolism and phenotype in hypoxic gradients
por: Rodenhizer, Darren, et al.
Publicado: (2015)

Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
por: Kerr, Emma, et al.
Publicado: (2016)

Metabolic Coordination of Pericyte Phenotypes: Therapeutic Implications
por: Nwadozi, Emmanuel, et al.
Publicado: (2020)

Connecting Metabolic Rewiring With Phenotype Switching in Melanoma
por: Falletta, Paola, et al.
Publicado: (2022)

Fumarate induces redox-dependent senescence by modifying glutathione metabolism
por: Zheng, Liang, et al.
Publicado: (2015)

Predicting metabolic biomarkers of human inborn errors of metabolism
por: Shlomi, Tomer, et al.
Publicado: (2009)

PREDICT: a method for inferring novel drug indications with application to personalized medicine
por: Gottlieb, Assaf, et al.
Publicado: (2011)

Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism
por: Jerby, Livnat, et al.
Publicado: (2010)

Splicing regulatory factors in breast cancer hallmarks and disease progression
por: Koedoot, Esmee, et al.
Publicado: (2019)

Metabolic predictors of response to immune checkpoint blockade therapy
por: Shorer, Ofir, et al.
Publicado: (2023)

Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery
por: van der Noord, Vera E., et al.
Publicado: (2022)

Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division
por: Ow, Jin Rong, et al.
Publicado: (2020)

Conservation of Expression and Sequence of Metabolic Genes Is Reflected by Activity Across Metabolic States
por: Bilu, Yonatan, et al.
Publicado: (2006)

Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
por: Kang, Yun Pyo, et al.
Publicado: (2019)

INDI: a computational framework for inferring drug interactions and their associated recommendations
por: Gottlieb, Assaf, et al.
Publicado: (2012)

A joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer
por: Auslander, Noam, et al.
Publicado: (2016)

An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer
por: Auslander, Noam, et al.
Publicado: (2017)

Correction: Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
por: Kang, Yun Pyo, et al.
Publicado: (2019)

A method for inferring medical diagnoses from patient similarities
por: Gottlieb, Assaf, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dr15heq23dtojgd8s08h41q4ot